CEPHEID Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2026-11: Study NCT03767231; Company role Collaborator; Phase Not applicable; Status Not yet recruiting.
- 2026-08-01: Study NCT07560046; Company role Collaborator; Phase Phase 4; Status Not yet recruiting.
- 2026-03: Study NCT07307300; Company role Collaborator; Phase Observational; Status Not yet recruiting.
- 2025-08-18: Study NCT07520279; Company role Lead sponsor; Phase Observational; Status Enrolling by invitation.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2026-11 | NCT03767231 ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing | Collaborator Lead: Johns Hopkins University | Not applicable | Not yet recruiting | Hepatitis C | 200 | 2027-11 |
| 2026-08-01 | NCT07560046 Combating Related Epidemics in HCV | Collaborator Lead: Duke University | Phase 4 | Not yet recruiting | HIV - Human Immunodeficiency Virus; Hepatitis B Virus (HBV); HEPATITIS C (HCV) | 1,280 | 2030-12-30 |
| 2026-03 | NCT07307300 Study on Risk Assessment for Patients With Microscopic Hematuria (Non-Visible Blood in Urine) Using a Urine Marker Test | Collaborator Lead: Christian Bolenz | Observational | Not yet recruiting | Hematuria | 1,475 | 2028-06 |
| 2025-08-18 | NCT07520279 Xpert® Tropical Fever Test on GeneXpert® Edge X System | Lead sponsor | Observational | Enrolling by invitation | Malaria Fever; Zika; Dengue Fever; Leptospirosis; Chikungunya Virus Infection | 2,500 | 2027-02-28 |
| 2025-05-13 | NCT07489846 Xpert® ERP on the GeneXpert® System | Lead sponsor | Observational | Completed | Respiratory Tract Infections | 3,200 | 2026-02-02 |
| 2025-01-13 | NCT07370454 Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System | Lead sponsor | Observational | Completed | Hemorrhagic Fever | 408 | 2025-10-03 |
| 2024-10-21 | NCT07591740 Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users | Lead sponsor | Observational | Completed | Hemorrhagic Fever | 725 | 2026-03-13 |
| 2024-06-16 | NCT06438575 Point of Care Diagnosis of Vaginal Infections | Collaborator Lead: Sharon L Hillier | Not applicable | Completed Results posted | Vaginitis; Bacterial Vaginosis; Yeast Vaginitis; Trichomonas Vaginitis | 351 | 2025-03-26 |
| 2024-02-06 | NCT06508996 Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System | Lead sponsor | Observational | Completed | HCV | 1,012 | 2024-06-06 |
| 2023-12-28 | NCT06281691 GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit | Collaborator Lead: Jørgen Bjerggaard Jensen | Observational | Completed | Urinary Bladder Neoplasms | 127 | 2025-12-30 |
| 2022-04-14 | NCT04878328 Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO | Collaborator Lead: Montefiore Medical Center | Not applicable | Completed Results posted | Covid19 | 250 | 2025-05-22 |
| 2021-08-18 | NCT04793750 Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC) | Collaborator Lead: Johns Hopkins University | Not applicable | Completed Results posted | HIV Infections; Syphilis | 224 | 2025-03-31 |
| 2020-11-17 | NCT04610762 HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels | Collaborator Lead: Centre Hospitalier Universitaire Saint Pierre | Observational | Completed | Hepatitis C, Chronic | 103 | 2022-11-17 |
| 2019-11-01 | NCT04100733 Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor | Collaborator Lead: Jørgen Bjerggaard Jensen | Not applicable | Active not recruiting | Non-muscle Invasive Bladder Cancer; Urinary Biomarker | 392 | 2027-04 |
| 2019-07-11 | NCT03728725 Xpert MTB/XDR Clinical Evaluation Trial | Collaborator Lead: Foundation for Innovative New Diagnostics, Switzerland | Observational | Completed | Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant | 710 | 2020-08-18 |
| 2019-06-01 | NCT03936816 The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis | Collaborator Lead: Carmel Medical Center | Observational | Completed | GBS | 303 | 2020-08-30 |
| 2019-05-22 | NCT04647981 Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test. | Collaborator Lead: Clinique Beau Soleil | Observational | Completed | Non-Invasive Bladder Urothelial Carcinoma; Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade; Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade | 320 | 2021-01-02 |
| 2019-01-21 | NCT03734172 Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) | Collaborator Lead: Michael Hoelscher | Observational | Completed | Tuberculosis; Diagnoses Disease | 974 | 2022-12-31 |
| 2018-06-06 | NCT03664258 A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) | Lead sponsor | Observational | Completed | Non-muscle-invasive Bladder Cancer | 852 | 2022-01-31 |
| 2018-03-01 | NCT03715660 Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study | Collaborator Lead: Mansoura University | Not applicable | Completed | Bladder Cancer | 198 | 2019-10-01 |
| 2017-11-08 | NCT03421626 Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) | Lead sponsor | Observational | Completed | Leukemia, Myelogenous, Chronic | 266 | 2018-08-20 |
| 2017-01 | NCT02755402 Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs | Collaborator Lead: Centre hospitalier de l'Université de Montréal (CHUM) | Not applicable | Completed | Hepatitis C; Intravenous Drug Users | 103 | 2021-05 |
| 2016-12-01 | NCT02922816 FMT for MDRO Colonization After Infection in Renal Transplant Recipients | Collaborator Lead: Emory University | Phase 1 | Terminated | Infection Due to Resistant Organism | 11 | 2021-12-03 |
| 2016-12 | NCT03125460 Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer | Lead sponsor | Observational | Completed | Bladder Cancer | 424 | 2019-05 |
| 2016-08 | NCT02895620 Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC | Collaborator Lead: Institut Claudius Regaud | Not applicable | Unknown | Non Muscle Invasive Bladder Cancer; Treatment by BCG | 24 | 2017-08 |
| 2016-06 | NCT02386514 Emergency Department, Rapid Assessment for Sexually Transmitted Infection | Collaborator Lead: Henry Ford Health System | Observational | Completed | Infection | 1,200 | 2016-06 |
| 2015-07 | NCT02461576 Clinical Evaluation of the Xpert® HIV-1 VL | Lead sponsor | Observational | Completed | Human Immunodeficiency Virus | 966 | 2017-02-24 |
| 2013-10 | NCT01989130 Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED | Collaborator Lead: George Washington University | Not applicable | Completed Results posted | Reproductive Tract Infections | 70 | 2015-03 |
| 2012-05 | NCT01587469 Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects | Lead sponsor | Observational | Completed | Tuberculosis | 992 | 2014-02-21 |
| 2011-10 | NCT01813500 Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients | Collaborator Lead: Boston Medical Center | Observational | Completed | Crohn's Disease; Ulcerative Colitis; Clostridium Difficile; Inflammatory Bowel Disease | 400 | 2016-04 |
| 2008-04 | NCT01198262 Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections | Collaborator Lead: Michael E. DeBakey VA Medical Center | Observational | Completed | Staphylococcus Aureus; Staphylococcal Skin Infections; Bacteremia | 260 | 2010-08 |